Hyperphosphatemia: all 152 studies
Page 2 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Safety and Tolerability Study of MCI-196TerminatedNCT01818687Phase 3
- Long-term Extension Study of MCI-196TerminatedNCT01814917Phase 3
- Dose-finding Study of MCI-196TerminatedNCT01814904Phase 3
- Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis PatientsCompletedNCT01755078Phase 4
- Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742611Phase 3
- A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on DialysisCompletedNCT01742585Phase 3
- Outcome Study of Lanthanum Carbonate Compared With Calcium Carbonate in Hemodialysis Patients : Landmark StudyCompletedNCT01578200Phase 3
- Open Study of BAY77-1931 (Lanthanum Carbonate) in Continuous Ambulatory Peritoneal Dialysis PatientsCompletedNCT01518387Phase 3
- Phase III Double-blind Comparative Study of BAY77-1931 (Lanthanum Carbonate) With Calcium CarbonateCompletedNCT01514851Phase 3
- A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of the Effects of Ferric Citrate in Subjects With End Stage Renal DiseaseCompletedNCT01503736Phase 3
- Non-interventional Study to Evaluate the Ease of Reaching Individual Goals in Serum Phosphorus (Steering)CompletedNCT01424787
- Fosrenol Post-marketing Surveillance for Hemodialysis in JapanCompletedNCT01419327
- Fosrenol Post-marketing Surveillance for Continuous Cyclic Peritoneal Dialysis in JapanCompletedNCT01412398
- The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) PatientsStatus unknownNCT01329497Not applicable
- PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing GumCompletedNCT01319578Not applicable
- Phosphate Kinetic Modeling 2CompletedNCT01252771Phase 4
- The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis PatientStatus unknownNCT01245517Not applicable
- Nicotinamide in Hemodialysis Patients With HyperphosphatemiaCompletedNCT01200784Phase 2
- Long-term Study in Chronic Kidney Disease (Extension From Study 14817)CompletedNCT01187628Phase 3
- Study in Chronic Kidney Disease (CKD) Not on DialysisCompletedNCT01110629Phase 3
- Placebo Versus SBR759 in Lowering Phosphate in Dialysis PatientsCompletedNCT01069692Phase 3
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT01057407Phase 3
- Hypophosphatemic Rickets in NorwayStatus unknownNCT01057186
- Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and HyperphosphatemiaCompletedNCT01057108Phase 1
- Bioequivalence Study of BAY77-1931 GranuleCompletedNCT01053676Phase 1
- A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal DialysisCompletedNCT01017276Phase 3
- Phosphate Kinetic ModelingCompletedNCT01003223Not applicable
- Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisCompletedNCT00892749Phase 3
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Sevelamer HydrochlorideTerminatedNCT00844662Phase 3
- Phase III Study to Investigate the Safety and Efficacy of Fermagate and Lanthanum CarbonateTerminatedNCT00841126Phase 3
- Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)WithdrawnNCT00837655Not applicable
- An Open Label Trial to Evaluate the Effects of a Novel Renal Multivitamin on Inflammation and Other Biomarkers in Endstage Renal Disease PatientsStatus unknownNCT00834301Phase 2
- A Randomised, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Sevelamer Carbonate Tablets Dosed Three Times a Day in Hyperphosphataemic Chronic Kidney Disease Patients Not on DialysisTerminatedNCT00833768Phase 3
- BAY 77-1931 Long-term Extension From Phase II StudyCompletedNCT00769496Phase 2
- Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in BoneCompletedNCT00767637Phase 2
- Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy VolunteersCompletedNCT00742820Phase 1
- Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on HemodialysisCompletedNCT00704483Phase 2
- An Open Label Dose Titration of Sevelamer Carbonate Tabs 3 Times a Day in Hyperphosphatemic CKD Patients Not On DialysisCompletedNCT00681941Phase 3
- Phosphorus Improvement Pilot StudyCompletedNCT00583570Not applicable
- Long Term Treatment of End Stage Renal Disease Patients With Lanthanum Carbonate (Fosrenol)CompletedNCT00567723
- Study to Assess Fixed Dosing of AMG 223 in Subjects With Chronic Kidney Disease on Hemodialysis With HyperphosphatemiaCompletedNCT00530114Phase 2
- The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis PatientsCompletedNCT00508885Phase 1/2
- A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedNCT00505037Phase 2
- Efficacy of Phosphate Binding in Healthy Volunteers: Chewed Versus Crushed Lanthanum CarbonateCompletedNCT00458289Phase 1
- A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With HyperphosphatemiaTerminatedNCT00451295Phase 3
- Dose Ranging Study of Magnesium Iron Hydroxycarbonate in Haemodialysis Subjects With HyperphosphataemiaCompletedNCT00436683Phase 2
- Klotho Gene Polymorphism in Dialyzed Patients With HyperphosphatemiaTerminatedNCT00374712
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium AcetateWithdrawnNCT00364000Not applicable
- Efficacy and Tolerability of ILY101 in Dialysis Patients With HyperphosphatemiaStatus unknownNCT00358046Phase 2
- Efficacy and Safety Study of Magnesium Iron Hydroxycarbonate for the Reduction of High Blood Phosphate in Hemodialysis PatientsCompletedNCT00317694Phase 2
- The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis PatientsCompletedNCT00316472Phase 1
- EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease)CompletedNCT00211978Phase 3